Papa John’s International (NASDAQ:PZZA – Free Report) had its price objective reduced by Piper Sandler from $30.00 to $26.00 in a report issued on Friday,Benzinga reports. They currently have a neutral rating on the stock. A number of other brokerages have also recently issued reports on PZZA. Benchmark cut shares of Papa John’s International from […]
| # | Наименование новости | Тональность | Информативность | Дата публикации |
|---|---|---|---|---|
| 1 | Piper Sandler Cuts Restaurant Brands International (NYSE:QSR) Price Target to $81.00 | 0 | 12.25 | 10-08-2026 |
| 2 | Piper Sandler Cuts Molson Coors Beverage (NYSE:TAP) Price Target to $44.00 | 0 | 9.52 | 10-08-2026 |
| 3 | Piper Sandler Cuts Amphastar Pharmaceuticals (NASDAQ:AMPH) Price Target to $20.00 | 0 | 11.9 | 10-08-2026 |
| 4 | Piper Sandler Cuts ResMed (NYSE:RMD) Price Target to $225.00 | 0 | 10.45 | 10-08-2026 |
| 5 | Piper Sandler Cuts Abacus Global Management (NYSE:ABX) Price Target to $12.00 | 0 | 10.81 | 10-08-2026 |
| 6 | Piper Sandler Cuts Celsius (NASDAQ:CELH) Price Target to $36.00 | 0 | 12.64 | 10-08-2026 |
| 7 | Five9 (NASDAQ:FIVN) Price Target Raised to $30.00 | 0 | 14.6 | 10-08-2026 |
| 8 | Somnigroup International’s (SGI) “Overweight” Rating Reiterated at Piper Sandler | 0 | 9.05 | 10-08-2026 |
| 9 | Shoulder Innovations’ (SI) Overweight Rating Reiterated at Piper Sandler | 0 | 8.45 | 10-08-2026 |
| 10 | Collegium Pharmaceutical’s (COLL) “Neutral” Rating Reiterated at Piper Sandler | 0 | 9.68 | 10-08-2026 |